MA30072B1 - Masquage de gout pour poudres - Google Patents

Masquage de gout pour poudres

Info

Publication number
MA30072B1
MA30072B1 MA31056A MA31056A MA30072B1 MA 30072 B1 MA30072 B1 MA 30072B1 MA 31056 A MA31056 A MA 31056A MA 31056 A MA31056 A MA 31056A MA 30072 B1 MA30072 B1 MA 30072B1
Authority
MA
Morocco
Prior art keywords
powders
taste masking
masked
inhalation
intended
Prior art date
Application number
MA31056A
Other languages
English (en)
French (fr)
Inventor
Rainer Bellinghausen
Daniel Rudhardt
Frank Ridder
Martin Steinbeck
Jesko Zank
Martin Weiss
Olaf Behrend
Stiphout Udo Van
Original Assignee
Bayer Technology Services Gmbh
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Bayer Technology Services Gmbh filed Critical Bayer Technology Services Gmbh
Publication of MA30072B1 publication Critical patent/MA30072B1/fr

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/007—Pulmonary tract; Aromatherapy
    • A61K9/0073—Sprays or powders for inhalation; Aerolised or nebulised preparations generated by other means than thermal energy
    • A61K9/0075—Sprays or powders for inhalation; Aerolised or nebulised preparations generated by other means than thermal energy for inhalation via a dry powder inhaler [DPI], e.g. comprising micronized drug mixed with lactose carrier particles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
    • A61K9/1605—Excipients; Inactive ingredients
    • A61K9/1617—Organic compounds, e.g. phospholipids, fats
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
    • A61K9/1682—Processes
    • A61K9/1688—Processes resulting in pure drug agglomerate optionally containing up to 5% of excipient
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
    • A61K9/5005—Wall or coating material
    • A61K9/5015—Organic compounds, e.g. fats, sugars
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
    • A61K9/5089—Processes
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents

Landscapes

  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Biophysics (AREA)
  • Otolaryngology (AREA)
  • Pulmonology (AREA)
  • Molecular Biology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Medicinal Preparation (AREA)
  • Seasonings (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
MA31056A 2005-12-24 2008-06-19 Masquage de gout pour poudres MA30072B1 (fr)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE102005062270A DE102005062270A1 (de) 2005-12-24 2005-12-24 Geschmacksmaskierung von Pulvern

Publications (1)

Publication Number Publication Date
MA30072B1 true MA30072B1 (fr) 2008-12-01

Family

ID=38042692

Family Applications (1)

Application Number Title Priority Date Filing Date
MA31056A MA30072B1 (fr) 2005-12-24 2008-06-19 Masquage de gout pour poudres

Country Status (24)

Country Link
US (1) US20090269411A1 (https=)
EP (1) EP1968555A2 (https=)
JP (2) JP5275039B2 (https=)
KR (2) KR101245627B1 (https=)
CN (1) CN101346133A (https=)
AU (1) AU2006331009B2 (https=)
BR (1) BRPI0620618A2 (https=)
CA (1) CA2634481A1 (https=)
CR (1) CR10112A (https=)
CU (1) CU23877B1 (https=)
DE (1) DE102005062270A1 (https=)
EC (1) ECSP088577A (https=)
GT (1) GT200800126A (https=)
HN (1) HN2008000964A (https=)
IL (1) IL192085A0 (https=)
MA (1) MA30072B1 (https=)
MY (1) MY149601A (https=)
NZ (1) NZ569279A (https=)
RU (1) RU2440103C2 (https=)
SV (1) SV2009002971A (https=)
TN (1) TNSN08284A1 (https=)
UA (1) UA93072C2 (https=)
WO (1) WO2007073911A2 (https=)
ZA (1) ZA200805498B (https=)

Families Citing this family (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB0327723D0 (en) 2003-09-15 2003-12-31 Vectura Ltd Pharmaceutical compositions
EP2050437A1 (en) * 2007-10-15 2009-04-22 Laboratoires SMB Improved pharmaceutical dry powder compositions for inhalation.
NZ586666A (en) * 2008-02-13 2012-04-27 Bayer Schering Pharma Ag Estradiol-containing drug delivery system
EA018330B1 (ru) * 2008-02-13 2013-07-30 Байер Интеллекчуал Проперти Гмбх Система доставки лекарственного средства со стабилизирующим эффектом
AU2009321822B2 (en) * 2008-12-05 2015-04-16 Elanco Animal Health Gmbh Extrudate having spicular active substances
WO2010111132A2 (en) 2009-03-27 2010-09-30 Bend Research, Inc. Spray-drying process
UY32836A (es) * 2009-08-12 2011-03-31 Bayer Schering Pharma Ag Partículas estabilizadas que comprenden 5-metil-(6s)-tetrahidrofolato
US20120207836A1 (en) 2009-08-19 2012-08-16 Bayer Pharma Aktiengesellschaft Drug delivery systems (wafer) for pediatric use
PT2611530T (pt) 2010-09-03 2019-05-09 Bend Res Inc Aparelho de secagem por pulverização e métodos de utilização do mesmo
US9084976B2 (en) 2010-09-03 2015-07-21 Bend Research, Inc. Spray-drying apparatus and methods of using the same
US8815294B2 (en) 2010-09-03 2014-08-26 Bend Research, Inc. Pharmaceutical compositions of dextran polymer derivatives and a carrier material
AU2011305572B2 (en) 2010-09-20 2016-08-04 Diane Goll Microencapsulation process and product
WO2012040502A1 (en) 2010-09-24 2012-03-29 Bend Research, Inc. High-temperature spray drying process and apparatus
HU231017B1 (hu) 2012-05-08 2019-11-28 LAVET Gyógyszeripari Kft. Praziquantel tartalmú ízfedett formulációk
US8993041B2 (en) * 2012-10-15 2015-03-31 New Jersey Institute Of Technology Taste masked active pharmaceutical powder compositions and processes for making them
WO2016067132A1 (en) 2014-10-31 2016-05-06 Bend Research Inc. Process for forming active domains dispersed in a matrix
CN114993892B (zh) * 2019-05-13 2024-10-18 南京制药厂有限公司 吡喹酮粒度的光散射检测法

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4568559A (en) * 1984-02-06 1986-02-04 Biotek, Inc. Composite core coated microparticles and process of preparing same
NL193682C (nl) * 1987-05-14 2000-07-04 Glaxo Group Ltd Beklede cefuroximaxetilsamenstelling.
KR20010042547A (ko) * 1998-04-09 2001-05-25 유란드 인터내셔날 에스.피.아. 소수성 폴리머로 코팅된 코어를 갖는 습윤성 마이크로캡슐
FR2811913B1 (fr) * 2000-07-19 2003-09-19 Separex Sa Procede d'encapsulation sous forme de micro-capsules de fines particules solides
GB2405798A (en) * 2003-09-15 2005-03-16 Vectura Ltd Dry powder inhaler with primary and secondary piercing elements and a medicament pack for use with an inhalation device.

Also Published As

Publication number Publication date
NZ569279A (en) 2011-06-30
CR10112A (es) 2009-01-07
AU2006331009B2 (en) 2012-10-04
DE102005062270A1 (de) 2007-06-28
ECSP088577A (es) 2008-07-30
JP5275039B2 (ja) 2013-08-28
RU2008130171A (ru) 2010-01-27
BRPI0620618A2 (pt) 2011-11-16
TNSN08284A1 (en) 2009-10-30
JP2013144695A (ja) 2013-07-25
KR20120006085A (ko) 2012-01-17
JP2009521419A (ja) 2009-06-04
EP1968555A2 (de) 2008-09-17
HN2008000964A (es) 2013-03-11
ZA200805498B (en) 2009-11-25
MY149601A (en) 2013-09-13
AU2006331009A1 (en) 2007-07-05
WO2007073911A2 (de) 2007-07-05
CN101346133A (zh) 2009-01-14
UA93072C2 (ru) 2011-01-10
US20090269411A1 (en) 2009-10-29
IL192085A0 (en) 2008-12-29
CA2634481A1 (en) 2007-07-05
WO2007073911A3 (de) 2007-08-23
KR101245627B1 (ko) 2013-03-20
CU23877B1 (es) 2013-04-19
KR20080081021A (ko) 2008-09-05
GT200800126A (es) 2010-06-25
CU20080124A7 (es) 2010-08-30
SV2009002971A (es) 2009-04-28
RU2440103C2 (ru) 2012-01-20

Similar Documents

Publication Publication Date Title
MA30072B1 (fr) Masquage de gout pour poudres
MA28581B1 (fr) Systemes voltametriques de titrage d'analytes biologiques
NO20053041D0 (no) Behandling av diabetes.
PT1413582E (pt) Pirrolobenzodiazepinas dimericas
EP1689379A4 (en) METHOD OF TREATING CANCER WITH HDAC INHIBITORS
BR0315296A (pt) Derivados do ciclohexanol espirocìclicos
DE60132600D1 (de) Medikamente zur chemotherapeutischen behandlung von erkrankungen
MA31145B1 (fr) Composition antivirale et procede d'utilisation
DK1117403T3 (da) MGLUR5-antagonister til behandling af smerte og angst
EA200700202A1 (ru) Гетероарильные соединения в качестве бетамиметиков для лечения заболеваний дыхательных путей
FR13C0044I2 (fr) Utilisation de dihydroimidazolones pour le traitement de l'epilepsie canine
IS7092A (is) Einfaldur skammtur af asíþrómýsíni til meðhöndlunar á sýkingum í öndunarvegi
NO20053623D0 (no) Derivater av prostaglandiner for behandling av abdominalt ubehag
DE59914712D1 (de) Verwendung von inhibitoren des kqt1-kanals zur herstellung eines medikaments zur behandlung von krankheiten, die durch helminthen und ektoparasiten hervorgerufen werden
EP1581243A4 (en) ORAL LACTOFERRIN FOR SEPSIS TREATMENT
NO20033804D0 (no) Karbamatforbindelser for behandling av smerte
ATE360428T1 (de) Analgetisches arzneimittel
TR200402230T4 (tr) O-ikameli 6-metil-tramadol-türevleri
EP1466168A4 (en) AMMONIUMIONOPHOR
BR0313230A (pt) Uso de carboxamidas para o tratamento de tinido
BRPI0411382A (pt) derivados de 2-aminobenzoil
NO20054034D0 (no) Fremgangsmate for behandling av hypotyroidisme.
DE502004003170D1 (de) Schmelzformulierte, multipartikuläre orale darreichungsform enthaltend clavulansäure
DE60315666D1 (de) Furopyridin- und furopyrimidinderivate zur behandlung von hyperproliferativen erkrankungen
SE0101258D0 (sv) Treatment of low back pain and whiplash associated disorder